O'Brien WE - Search Results

1

Requirement of argininosuccinate lyase for systemic nitric oxide production.

Erez A, Nagamani SC, Shchelochkov OA, Premkumar MH, Campeau PM, Chen Y, Garg HK, Li L, Mian A, Bertin TK, Black JO, Zeng H, Tang Y, Reddy AK, Summar M, O'Brien WE, Harrison DG, Mitch WE, Marini JC, Aschner JL, Bryan NS, Lee B. Erez A, et al. Among authors: o brien we. Nat Med. 2011 Nov 13;17(12):1619-26. doi: 10.1038/nm.2544. Nat Med. 2011. PMID: 22081021 Free PMC article.

2

Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism.

Scaglia F, Brunetti-Pierri N, Kleppe S, Marini J, Carter S, Garlick P, Jahoor F, O'Brien W, Lee B. Scaglia F, et al. J Nutr. 2004 Oct;134(10 Suppl):2775S-2782S; discussion 2796S-2797S. doi: 10.1093/jn/134.10.2775S. J Nutr. 2004. PMID: 15465784 Free article. Review.

3

Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.

Marini JC, Lanpher BC, Scaglia F, O'Brien WE, Sun Q, Garlick PJ, Jahoor F, Lee B. Marini JC, et al. Among authors: o brien we. Am J Clin Nutr. 2011 Jun;93(6):1248-54. doi: 10.3945/ajcn.110.009043. Epub 2011 Apr 13. Am J Clin Nutr. 2011. PMID: 21490144 Free PMC article. Clinical Trial.

4

Long-term correction of ornithine transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus.

Mian A, McCormack WM Jr, Mane V, Kleppe S, Ng P, Finegold M, O'Brien WE, Rodgers JR, Beaudet AL, Lee B. Mian A, et al. Mol Ther. 2004 Sep;10(3):492-9. doi: 10.1016/j.ymthe.2004.05.036. Mol Ther. 2004. PMID: 15336649 Free article.

5

Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.

Brunetti-Pierri N, Clarke C, Mane V, Palmer DJ, Lanpher B, Sun Q, O'Brien W, Lee B. Brunetti-Pierri N, et al. J Gene Med. 2008 Aug;10(8):890-6. doi: 10.1002/jgm.1218. J Gene Med. 2008. PMID: 18563850 Free PMC article.

6

Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.

Scaglia F, Carter S, O'Brien WE, Lee B. Scaglia F, et al. Mol Genet Metab. 2004 Apr;81 Suppl 1:S79-85. doi: 10.1016/j.ymgme.2003.11.017. Mol Genet Metab. 2004. PMID: 15050979

7

Evaluation of gene therapy for citrullinaemia using murine and bovine models.

Patejunas G, Lee B, Dennis JA, Healy PJ, Reeds PJ, Yu H, Frazer M, Mull B, Warman AW, Beaudet AL, O'Brien WE. Patejunas G, et al. J Inherit Metab Dis. 1998;21 Suppl 1:138-50. doi: 10.1023/a:1005322010854. J Inherit Metab Dis. 1998. PMID: 9686351

8

Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia.

Lee B, Dennis JA, Healy PJ, Mull B, Pastore L, Yu H, Aguilar-Cordova E, O'Brien W, Reeds P, Beaudet AL. Lee B, et al. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3981-6. doi: 10.1073/pnas.96.7.3981. Proc Natl Acad Sci U S A. 1999. PMID: 10097149 Free PMC article.

9

An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.

Scaglia F, Zheng Q, O'Brien WE, Henry J, Rosenberger J, Reeds P, Lee B. Scaglia F, et al. Pediatrics. 2002 Jan;109(1):150-2. doi: 10.1542/peds.109.1.150. Pediatrics. 2002. PMID: 11773558

10

Heritability of plasma amino acid levels in different nutritional states.

McBride KL, Belmont JW, O'Brien WE, Amin TJ, Carter S, Lee BH. McBride KL, et al. Mol Genet Metab. 2007 Feb;90(2):217-20. doi: 10.1016/j.ymgme.2006.08.010. Epub 2006 Sep 26. Mol Genet Metab. 2007. PMID: 17005426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page